Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J O'Callaghan

Showing results (591-600 of 601) with videos related to

Pageof 61
Sort By:
BMC Cancer|February 23, 2023
INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG)Lyn Ley Lam, Nick Pavlakis, Kohei Shitara, et al.
JCO Clinical Cancer Informatics|April 29, 2026
Deep Learning of Histopathology Predicts Outcomes After Surgery for Pancreatic CancerAvelyn Wong, Taib A Bourega, Rémy Nicolle, et al.
JCO Precision Oncology|October 5, 2020
Intratumoral Transcriptome Heterogeneity Is Associated With Patient Prognosis and Sidedness in Patients With Colorectal Cancer Treated With Anti-EGFR Therapy From the CO.20 TrialElisa Fontana, Gift Nyamundanda, David Cunningham, et al.
The New England Journal of Medicine|March 16, 2017
Short-Course Radiation plus Temozolomide in Elderly Patients with GlioblastomaJames R Perry, Normand Laperriere, Christopher J O'Callaghan, et al.
Nature Communications|April 7, 2020
Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel diseaseF J Ryan, A M Ahern, R S Fitzgerald, et al.
The New England Journal of Medicine|June 1, 2025
Structured Exercise after Adjuvant Chemotherapy for Colon CancerKerry S Courneya, Janette L Vardy, Christopher J O'Callaghan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2026
Clinical and molecular correlates of circulating tumor fraction in patients with metastatic pancreatic ductal adenocarcinomaJames T Topham, Haley M Beckmann, Joanna M Karasinska, et al.
Neuro-Oncology|March 19, 2024
Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trialPatrick Roth, Thierry Gorlia, Jaap C Reijneveld, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2026
Structured exercise program following adjuvant chemotherapy for colon cancer: A cost-utility analysis of the CHALLENGE trialKelvin Kw Chan, Ryan Wk Chu, Matthew C Cheung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2026
Adjuvant Durvalumab in Completely Resected Early-Stage Non-Small Cell Lung CancerGlenwood D Goss, Gail E Darling, Virginie Westeel, et al.
Pageof 61

Showing results (591-600 of 601) with videos related to

Sort By:
Pageof 61
BMC Cancer|February 23, 2023
INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG)Lyn Ley Lam, Nick Pavlakis, Kohei Shitara, et al.
JCO Clinical Cancer Informatics|April 29, 2026
Deep Learning of Histopathology Predicts Outcomes After Surgery for Pancreatic CancerAvelyn Wong, Taib A Bourega, Rémy Nicolle, et al.
JCO Precision Oncology|October 5, 2020
Intratumoral Transcriptome Heterogeneity Is Associated With Patient Prognosis and Sidedness in Patients With Colorectal Cancer Treated With Anti-EGFR Therapy From the CO.20 TrialElisa Fontana, Gift Nyamundanda, David Cunningham, et al.
The New England Journal of Medicine|March 16, 2017
Short-Course Radiation plus Temozolomide in Elderly Patients with GlioblastomaJames R Perry, Normand Laperriere, Christopher J O'Callaghan, et al.
Nature Communications|April 7, 2020
Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel diseaseF J Ryan, A M Ahern, R S Fitzgerald, et al.
The New England Journal of Medicine|June 1, 2025
Structured Exercise after Adjuvant Chemotherapy for Colon CancerKerry S Courneya, Janette L Vardy, Christopher J O'Callaghan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2026
Clinical and molecular correlates of circulating tumor fraction in patients with metastatic pancreatic ductal adenocarcinomaJames T Topham, Haley M Beckmann, Joanna M Karasinska, et al.
Neuro-Oncology|March 19, 2024
Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trialPatrick Roth, Thierry Gorlia, Jaap C Reijneveld, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2026
Structured exercise program following adjuvant chemotherapy for colon cancer: A cost-utility analysis of the CHALLENGE trialKelvin Kw Chan, Ryan Wk Chu, Matthew C Cheung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2026
Adjuvant Durvalumab in Completely Resected Early-Stage Non-Small Cell Lung CancerGlenwood D Goss, Gail E Darling, Virginie Westeel, et al.
Pageof 61